Precise Strategies to Uncover Biomarkers & Endpoints for Myeloid Cell Therapies
Time: 11:00 am
day: Pre-Conference Workshop Day
Details:
Biomarkers are often cheaper and easier to measure than ‘true’ endpoints. This workshop is designed to provide participants with comprehensive insights into the crucial process of selecting effective biomarkers and subsequent endpoints for measuring the full effect of myeloid therapies. Attendees will gain a deep understanding of the significance of biomarker selection in monitoring therapeutic outcomes and identifying relevant endpoints to assess the efficacy of myeloid cell-based interventions.
Join this workshop to:
- Discuss criteria for selecting effective biomarkers, including sensitivity, specificity, and feasibility
- Review real-world case studies highlighting successful biomarker selection for myeloid cell therapies
- Understand the relationship between selected biomarkers and clinically relevant endpoints and how they align with therapeutic goals and patient outcomes
- Gain an overview of regulatory requirements for biomarker and endpoint selection in myeloid cell therapy trials
